LONDON--(BUSINESS WIRE)-- Affecting 2.5 million people from pole to pole on an annual basis, multiple sclerosis (MS) is considered to be the most enfeebling neurological disease in young adults. In 2012, the United States had the highest number of both prevalent and incident cases among the ten markets covered, and will continue to keep this up until 2022.
Among the major factors considered to be impacting the regional differences in MS prevalence and incidence one can name diagnostic criteria utilized, medical technology availability, genetic and environmental risk factors, frequency of comorbidities, as well as population age and gender structure.
New market research report “EpiCast Report: Multiple Sclerosis Epidemiology Forecast to 2022” elaborated by GlobalData reviews the risk factors and global trends of the multiple sclerosis market worldwide with a focus of the countries such as the US, France, Germany, Italy, Spain, the UK, Japan, Canada, India and China. Additionally, a ten-year epidemiological forecast of multiple sclerosis prevalence and incidence segmented by gender, age, and multiple sclerosis subtypes in the ten markets.
Title: EpiCast Report: Multiple Sclerosis Epidemiology Forecast to 2022
Published: December, 2012
Price: US$ 6,995.00
More Life Sciences Market Research Reports by GlobalData Include:
More new in-demand market research reports by GlobalData can be found at http://marketpublishers.com/members/global_data/info.html
Source: The Market Publishers, Ltd.